CRISPR diagnostic enterprise Tolo Hong Kong bio completed tens of millions of yuan of financing, China Da win-win exclusive investment.

Guide: Tolo Port Biofinance Success, committed to in vitro diagnostic product development and registration.
recently, focusing on the "CRISPR Diagnostics" patented technology industrialization of Nanjing Tolo Port Biotechnology Co., Ltd. (hereinafter referred to as "Tolo Gang Bio") announced that the company has successfully completed tens of millions of yuan of financing, this round of financing will be mainly used for the company CRISPR diagnostic stoic patents - HOLMES technology in vitro diagnostic product development and registration, the establishment of GMP standards in vitro diagnostic product production workshop, and HOLMES technology global patent layout.
this round of financing by The Win-Win exclusive investment, while the subsidiary Wuxi Tolo Port Company received Wuxi City and Huishan Government, Wuxi Huishan Life Science and Technology Industrial Park industrial funds and policy support.
Founded by a leading academic team from the Chinese Academy of Sciences' Key Laboratory of Synthetic Biology and senior industry professionals from the molecular diagnostics industry, the company developed an innovative nucleic acid detection technology based on the CRISPR/Cas12 system in 2017 and named it "HOLMES", compared to traditional thermostatic testing, qPC R, NGS and other molecular diagnostic technology, HOLMES nucleic acid fast detection technology with high sensitivity, high specific, fast and other advantages, has also been the United States Science Magazine as "the next generation of molecular diagnostic technology", and in the pathogen detection, disease screening, precision medicine and many other fields have great potential for application.
Tolo Port Bio has a global patent for Cas12 protein in nucleic acid detection technology and applications, while the company has reached a cross-licensing of CRISPR basic patents with One of the pioneers of CRISPR gene editing technology, Professor Zhang Feng of MIT, etc., and further improved the patent moat of HOLMES technology.
in vitro diagnostics is the company's focus on the application area, the company will bring a new solution to the molecular detection market, but also actively with the vast number of in vitro diagnostics and biotechnology companies to achieve a win-win situation.
for the first round of financing completed during the outbreak of the company, Tolo Hong Kong Biological founder Dr. Wang Jin said: "Thank you very much for the new shareholder HuaDa Win-Win's recognition and support for the Tolo Gang team and technology, in the process of contact with Huada Win-Win Team, Huada Win-Win Team's professional and responsible spirit left a deep impression on me, Huada Win-Win not only to give Tolo Gang financial support, but also to help the company comb the development strategy, improve team building and equity structure, the company to find a variety of resources to help the development of the industry.
the company is now racing to accelerate the strategic layout of patents and the transformation of patented technology products.
" as an investment manager in charge of the project, Huada Win, an organization focused on bio-healthcare, said: "Tolu Gang Bio is the only company in China with three crispR diagnostic underlying methodology patents, and the innovation technology team led by Zhao Guoping and Dr. Wang Jin is founded jointly with senior industry operators in the IVD industry, and we believe that the team can quickly advance the continuous innovation and upgrading of this platform-based technology. Commercial applications, for example, in order to help the scientific and technological warfare epidemic, the company in February this year has been united with China Dazhi, etc. developed within an hour of the new coronavirus nucleic acid test report "fully enclosed new coronavirus fast detector", while the first new coronavirus detection products based on CRISPR technology developed by partner SherlockBiosciences was also approved by the U.S. FDA in early May this year. Liu Yu, managing partner of
", said: "I am very optimistic about HOLMES technology of Tolo Hong Kong Bio, which is one of the few patented technologies in China that independently develops the underlying levels of life science and technology, and its promotion and application will bring technological upgrading and even industrial revolution to molecular diagnostics."
the field of in vitro diagnostics has been a long-term concern of China University, we will continue to tap the field of outstanding enterprises, promote the rapid development of the field of molecular diagnostics.
"on China University win-win as a venture capital institution with the background of China's gene industry, advocate the "research and development-driven investment" professional investment concept, adhere to the mapping of the industry, the industry chain of active investment layout of investment methods, professional focus on gene technology, medical devices / high-value supplies, biomedicine and other key technology or platform-type projects; Large genes, Kantai biology, new industrial biology, Huada Zhizhi and other life sciences in the field of leading enterprises, the fund mainly to start-up, long-term projects, to achieve a reasonable allocation of the project investment stage;
.